Literature DB >> 17962479

Intraocular nanoparticle drug delivery: a pilot study using an aerosol during pars plana vitrectomy.

Guifang Zhang1, Xiao Feng, Kathy Wabner, Chris Fandrey, Amir Naqwi, Timothy Wiedmann, Timothy W Olsen.   

Abstract

PURPOSE: To describe a method of drug delivery to the retina via aerosolized nanoparticles in the gas phase during the gas-exchange stage of vitrectomy in a porcine model.
METHODS: An ultrasonically atomized and dried sodium fluorescein aerosol was produced with a concentration of 12 ng/mL and a mass median particle size of 407 nm. Eighteen porcine eyes were randomly divided into six groups and subjected to standard three-port pars plana vitrectomy. After the air-fluid exchange and during the gas exchange, the eyes were exposed to the aerosol, either as a steady flow through the chamber (3.6 microg/min) or as a single fill (50 ng) at three exposure times (three eyes/time point).
RESULTS: The flow-through delivery mode provided a relatively uniform deposition of aerosol on the inner surface of the retina, and longer delivery time led to an increase in the quantity deposited, with greater than 40 ng total deposition by 10 minutes. The single-fill method had uniform deposition but lower total delivery, approximately 10 ng by 60 minutes. Modeling of the data suggests that deposition in the flow-through mode is successful if the vitreous chamber contents are well mixed. The single-fill delivery was described by diffusion in a quiescent state.
CONCLUSIONS: This study demonstrates a novel method of drug delivery to the posterior pole by using aerosolized nanoparticles that may be used in the gas phase of vitrectomy. Therapeutic applications include antimetabolites for modulation of proliferative vitreoretinopathy, antimicrobial agents for endophthalmitis, antiangiogenic compounds for vasoproliferative disorders, corticosteroid delivery, and other pharmacotherapies directed at the retina and choroid.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17962479     DOI: 10.1167/iovs.07-0323

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  5 in total

1.  Nanoparticles in the ocular drug delivery.

Authors:  Hong-Yan Zhou; Ji-Long Hao; Shuang Wang; Yu Zheng; Wen-Song Zhang
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

2.  Immersion Biometry for Intraocular Lens Power Calculation with Fourth-Generation Formulas.

Authors:  Janusz Skrzypecki; Iwona Grabska-Liberek; Maria Guszkowska; Justyna Izdebska; Jacek P Szaflik
Journal:  Clin Ophthalmol       Date:  2020-07-28

3.  Drug delivery to posterior intraocular tissues: third Annual ARVO/Pfizer Ophthalmics Research Institute Conference.

Authors:  Henry F Edelhauser; Jeffrey H Boatright; John M Nickerson
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-15       Impact factor: 4.799

Review 4.  Nanoparticle-Mediated Delivery of Neuroprotective Substances for the Treatment of Diabetic Retinopathy.

Authors:  Rosario Amato; Massimo Dal Monte; Matteo Lulli; Vittoria Raffa; Giovanni Casini
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 5.  Vitreous Substitutes as Drug Release Systems.

Authors:  André Schulz; Peter Szurman
Journal:  Transl Vis Sci Technol       Date:  2022-09-01       Impact factor: 3.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.